Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 53 (2019): Issue 1 (March 2019)
Open Access
NADPH oxidase inhibitor VAS2870 prevents staurosporine-induced cell death in rat astrocytes
Janez Simenc
Janez Simenc
,
Damijana Mojca Juric
Damijana Mojca Juric
and
Metoda Lipnik-Stangelj
Metoda Lipnik-Stangelj
| Jan 19, 2019
Radiology and Oncology
Volume 53 (2019): Issue 1 (March 2019)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Jan 19, 2019
Page range:
69 - 76
Received:
Sep 24, 2018
Accepted:
Nov 18, 2018
DOI:
https://doi.org/10.2478/raon-2019-0002
© 2019 Janez Simenc, Damijana Mojca Juric, Metoda Lipnik-Stangelj, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1
The effect of staurosporine on viability of rat astrocytes. Representative flow cytometric experiment is showing the uptake of 7-AAD vital dye in rat astrocytes. The percentages of dead cells with high red fluorescence intensity are shown in rectangular regions. (A) The control cells were not treated. (B) The cells were exposed to 1 μM staurosporine. (C) The cells were exposed to 10 μM VAS2870. (D) The cells were pre-treated with 10 μM VAS2870 and exposed to 1 μM staurosporine. (E) The percentages of dead cells as determined by 7-AAD uptake. (Con) The control cells were not treated. (STS) The cells were exposed to 1 μM staurosporine. (STS+VAS2870) The cells were pre-treated with 5 or 10 μM VAS2870 and exposed to 1 μM staurosporine. (VAS2870) The cells were exposed to 5 or 10 μM VAS2870. Data were analysed using one-way ANOVA and a Tukey multiple comparison test; p < 0.05 indicates significance.
Figure 2
(A) The effect of staurosporine on caspases-3/7 activation and (B) level of intracellular ATP. (STS) The cells were exposed to 1 μM staurosporine. (Con) The control cells were not treated. (STS+VAS2870) The cells were pre-treated with 10 μM VAS2870 and exposed to 1 μM staurosporine. (VAS2870) The cells were exposed to 10 μM VAS2870. (STS + z-vad-fmk) The cells were pre-treated with 20 μM z-vad-fmk and exposed to 1 μM staurosporine. (z-vad-fmk) The cells were exposed to 20 μM z-vad-fmk. Data were analysed using one-way ANOVA and a Tukey multiple comparison test; *p < 0.05 vs. Con, **p < 0.05 vs. STS, ***p < 0.05 vs STS + VAS2870 indicate significance. RLU- relative luminescence units.
Figure 3
Representative flow cytometric experiment is showing detection of ROS production in rat astrocytes after staurosporine activation. The percentages of cells with high DCF fluorescence intensity are shown in rectangular regions. (A) Untreated control cells. (B) The cells were exposed to 1 μM staurosporine. (C) The cells were exposed to 10 μM VAS2870. (d) The cells were pre-treated with 10 μM VAS2870 and exposed to 1 μM staurosporine. (E) Production of ROS, detected as the percentage of cells with high DCF fluorescence intensity. (STS) The cells were exposed to 1 μM staurosporine. (Con) Untreated control cells. (STS + VAS2870) The cells were pre-treated with 5 or 10 μM VAS2870 and exposed to 1 μM staurosporine. (VAS2870) The cells were exposed to 5 or 10 μM VAS2870. Data were analysed using one-way ANOVA and a Tukey multiple comparison test; p < 0.05 indicates significance.
Figure 4
A representative flow cytometric experiment is showing the DiOC6(3) fluorescence intensity in rat astrocytes. The markers show the percentage of cells with reduced mitochondrial potential. (A) Untreated control cells. (B) The cells were exposed to 1 μM staurosporine. (C) The cells were exposed to 10 μM VAS2870. (D) The cells were pre-treated with 10 μM VAS2870 and exposed to 1 μM staurosporine. (E) The reduction of mitochondrial potential, detected as the percentage of low DiOC6(3) fluorescence. (STS) The cells were exposed to 1 μM staurosporine. (Con) Untreated control cells. (STS+VAS2870) The cells were pre-treated with 5 or 10 μM VAS2870 and exposed to 1 μM staurosporine. (VAS2870) The cells were exposed to 5 or 10 μM VAS2870. Data were analysed using one-way ANOVA and a Tukey multiple comparison test; p < 0.05 indicates significance.
Preview